BC
OLMA icon

Birchview Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Birchview Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Sell
199,000
-20,000
-9% -$268K 1.16% 21
2026
Q1 		$3.27M Sell
219,000
-50,000
-19% -$1.11M 1.86% 15
2025
Q4 		$6.72M Buy
269,000
+95,000
+55% +$1.69M 3.94% 6
2025
Q3 		$1.7M Buy
174,000
+40,000
+30% +$240K 1.29% 22
2025
Q2 		$571K Buy
+134,000
New +$597K 0.57% 37

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Birchview Capital's OLMA Position: Q2 2026 in Review

Birchview Capital reduced its Olema Pharmaceuticals (OLMA) stake by 9.1% in Q2 2026, selling an estimated $268K and leaving 199,000 shares worth $2.49M. The position accounts for 1.16% of the portfolio, ranked #21.

Birchview Capital first reported a position in OLMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.72M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Birchview Capital held 199,000 shares of Olema Pharmaceuticals worth $2.49M as of Q2 2026.
  • Birchview Capital sold 20,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $268K.
  • Olema Pharmaceuticals made up 1.16% of Birchview Capital's portfolio in Q2 2026, its #21 holding.
  • Birchview Capital first reported a position in Olema Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Birchview Capital's Olema Pharmaceuticals position peaked at $6.72M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.